Sharon Worcester is an award-winning medical journalist for MDedge News. She has been with the company since 1996, first as the Southeast Bureau Chief (1996-2009) when the company was known as International Medical News Group, then as a freelance writer (2010-2015) before returning as a reporter in 2015. She previously worked as a daily newspaper reporter covering health and local government. Sharon currently reports primarily on oncology and hematology. She has a BA from Eckerd College and an MA in Mass Communication/Print Journalism from the University of Florida. Connect with her via LinkedIn and follow her on twitter @SW_MedReporter.
News
Short-course DAA regimens for HCV provide limited cure rates
Four weeks of three- or four-agent direct-acting antiviral therapy was well tolerated, but less than a third of non-cirrhotic patients with...
News
ARC-520 shows promise in chronic hepatitis B
ARC-520, the first RNA interference–based drug to reach patients, produced deep and durable knockdown of viral antigens and DNA in chronic...
News
AASLD: Pilot study shows value of response-guided therapy for HCV GT1b
Response-guided therapy using all-oral triple direct-acting antiviral therapy appears useful for shortening the duration of treatment in...
News
Transplant waiting-list registrations dropped after direct acting–antiviral approval
The number of new waiting-list registrations for liver transplantation among patients with hepatitis C virus declined significantly after the...
News
Interferon-free treatment combo looks promising for HCV GT2, GT3 infection
The investigational combination of ombitasvir, paritaprevir, and ritonavir when given with sofosbuvir (OBV/PTV/r + SOF) appears to be a highly...
News
Novel botanical drug reduces hepatic fat content
Twelve weeks of treatment with a novel botanical drug extracted from Magnolia officinalis safely and significantly reduced hepatic fat content in...
News
Cysteamine bitartrate provides no histologic improvement in children with NAFLD
One year of treatment with delayed-release cysteamine bitartrate was safe and associated with substantial and rapid improvements in liver enzymes...
News
ASTRAL-1: High SVR12 with sofosbuvir/velpatasvir combo for HCV
Once-daily treatment with fixed-dose combination sofosbuvir/velpatasvir for 12 weeks was well tolerated and resulted in high sustained virologic...
Video
VIDEO: Ledipasvir/sofosbuvir highly effective in treatment-naive HCV GT1
Combination treatment with ledipasvir/sofosbuvir is highly effective for treatment-naive hepatitis C virus genotype 1 patients in routine medical...
News
Iron deficiency may explain persistent hypothyroidism symptoms
Between 30% and 50% of hypothyroid patients with persistent symptoms despite adequate levothyroxine therapy may have covert iron deficiency,...
News
LT4 therapy for SCH may improve pregnancy outcomes
Levothyroxine therapy during pregnancy in women with subclinical hypothyroidism was associated with a decrease in low birth weight and low Apgar...
News
ITC 2015: Review IDs features to aid thyroid lymphoma diagnosis
Rapidly enlarging thyroid masses with compressive symptoms may signal thyroid lymphoma, according to findings from a review of cases at the Mayo...
News
Early A-bomb radiation not linked to thyroid function
No link was found between atomic bomb radiation exposure in childhood and autoimmune thyroid disease or thyroid dysfunction in a study of nearly 2...
News
TCT: Bivalirudin no better than heparin for preventing post-TAVR bleeding
The reversible direct thrombin inhibitor bivalirudin did not reduce the rate of major bleeding at 48 hours after transcatheter aortic valve...
News
TCT: Extended follow-up supports PFO closure in cryptogenic stroke
Closure of the patent foramen ovale by way of a small investigational medical device inserted via the leg vein is more effective than is medical...